(1) "Advisory board" means the MAT expansion advisory board created in section 23-21-805.

(2) "College of nursing" means the college of nursing at the university of Colorado Anschutz medical campus, operated by the board of regents of the university of Colorado.

(3) "Federal act" means section 303 of the federal "Comprehensive Addiction and Recovery Act of 2016", Pub.L. 114-198.

(4) "Medication-assisted treatment" or "MAT" means a combination of behavioral therapy and medications, such as buprenorphine and all other medications and therapies, approved by the federal food and drug administration to treat opioid use disorder.

(5) "Nurse practitioner" means an advanced practice nurse, as defined in section 12-38-103 (1.5), who is listed on the advanced practice registry in accordance with section 12-38-111.5 and is authorized by the state board of nursing in accordance with section 12-38-111.6 to prescribe controlled substances and prescription drugs.

(6) "Physician assistant" means a person licensed as a physician assistant by the Colorado medical board in accordance with section 12-36-107.4 who is authorized, in accordance with section 12-36-106 (5), to perform acts constituting the practice of medicine, including prescribing controlled substances, and who is under the supervision of a physician trained in MAT.

(7) "Pilot program" or "MAT expansion pilot program" means the medication-assisted treatment expansion pilot program created in section 23-21-804.

(8) "Pilot program area" means the areas of the state in which the pilot program is available, as specified in section 23-21-804 (1)(b).

(9) "Qualified nurse practitioner or physician assistant" means a nurse practitioner or physician assistant who is a qualifying practitioner, as defined in the federal act and regulations adopted under the federal act, and is registered in accordance with 21 U.S.C. sec. 823 (g).